Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V

Karoline V. Gleixner, Barbara Peter, Katharina Blatt, Verena Suppan, Andreas Reiter, Deepti Radia, Emir Hadzijusufovic, Peter Valent*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    39 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science